Provided by Tiger Trade Technology Pte. Ltd.

Omnicell

35.82
+0.99002.84%
Post-market: 35.820.00000.00%19:30 EDT
Volume:303.07K
Turnover:10.85M
Market Cap:1.63B
PE:42.57
High:36.05
Open:35.25
Low:35.17
Close:34.83
52wk High:55.00
52wk Low:29.06
Shares:45.44M
Float Shares:43.94M
Volume Ratio:0.62
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8415
EPS(LYR):0.0400
ROE:3.06%
ROA:1.52%
PB:1.26
PE(LYR):895.50

Loading ...

Press Release: Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026

Dow Jones
·
Yesterday

Omnicell to Report Q3 2026 Results, Host Conference Call

Reuters
·
Yesterday

StoneX's New Best Ideas List: 5 Stocks In, 3 Stocks Out

Analyst Calls
·
Oct 02

Omnicell, TraceLink Integrate DSCSA Compliance Tools into Hospital Pharmacy Workflows

Reuters
·
Sep 03

Omnicell, TraceLink integrate DSCSA solution into hospital pharmacy operations

TIPRANKS
·
Sep 03

Omnicell management to meet with Piper Sandler

TIPRANKS
·
Sep 01

Omnicell to Present at Wells Fargo Annual Healthcare Conference

Reuters
·
Sep 01

Omnicell President and COO Nnamdi Njoku Reports Disposal of 6,753 Common Shares Worth $250,779.55

Reuters
·
Aug 19

Omnicell (OMCL) Could Be 40% Undervalued Following Strong Q2 Earnings And Guidance Raised

Simply Wall St.
·
Aug 08

Omnicell management to meet virtually with Freedom Capital

TIPRANKS
·
Aug 07

Omnicell Price Target Cut to $45.00/Share from $55.00 by Piper Sandler

Dow Jones
·
Aug 04

Omnicell Inc. : Wells Fargo Cuts Target Price to $50 from $55

THOMSON REUTERS
·
Jul 31

Omnicell is Maintained at Overweight by Keybanc

Dow Jones
·
Jul 31

Omnicell price target lowered to $50 from $55 at Wells Fargo

TIPRANKS
·
Jul 31

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 31

Omnicell Unit EnlivenHealth Launches VaxReach Vaccine Outreach Program for Pharmacies

Reuters
·
Jul 31

Stronger Q2 Results And Higher 2026 Guidance Might Change The Case For Investing In Omnicell (OMCL)

Simply Wall St.
·
Jul 31

Omnicell Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Omnicell Publishes Investor Presentation Outlining Autonomous Pharmacy Strategy, Titan XT and OmniSphere Platform Rollout

Reuters
·
Jul 30

Omnicell Q2 Adjusted EPS Beats Estimates, but Tightens 2026 Revenue Guidance

Reuters
·
Jul 30